Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL609162

CCCC[n+]1ccccc1.O=S(=O)([O-])C(F)(F)F

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 7/20 0.53
ACHE P22303 3/20 0.53
CHRM2 P08172 2/20 0.53
ADRA2A P08913 2/20 0.53
ADORA3 P0DMS8 2/20 0.53
CHRM1 P11229 2/20 0.53
SLC6A2 P23975 2/20 0.53
SLC6A4 P31645 2/20 0.53
SLC6A3 Q01959 2/20 0.53
ABCB11 O95342 1/20 0.53
ESR1 P03372 1/20 0.53
PGR P06401 1/20 0.53
HTR1A P08908 1/20 0.53
DRD1 P21728 1/20 0.53
TBXA2R P21731 1/20 0.53
PTGS1 P23219 1/20 0.53
PDE4A P27815 1/20 0.53
ADRA1A P35348 1/20 0.53
OPRM1 P35372 1/20 0.53
DRD3 P35462 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL16699863 0.95 KCNH2 (0.61) KCNH2ACHECHRM2ADRA2AADORA3
Trifluoromethanesulfonic Acid SCHEMBL14860035 0.94 KCNH2 (0.47) KCNH2ACHECHRM2ADRA2AADORA3
Trifluoromethanesulfonic Acid SCHEMBL29252066 0.93 KCNH2 (0.65) KCNH2ACHECHRM2ADRA2AADORA3
Trifluoromethanesulfonic Acid SCHEMBL712183 0.93 KCNH2 (0.65) KCNH2ACHECHRM2ADRA2AADORA3
Trifluoromethanesulfonic Acid SCHEMBL29252544 0.93 KCNH2 (0.65) KCNH2ACHECHRM2ADRA2AADORA3
Cetylpyridinium SCHEMBL28390298 0.93 KCNH2 (0.65) KCNH2ACHECHRM2ADRA2AADORA3
Trifluoromethanesulfonic Acid SCHEMBL28372122 0.93 KCNH2 (0.65) KCNH2ACHECHRM2ADRA2AADORA3
SCHEMBL16036661 0.92 KCNH2 (0.49) KCNH2ACHECHRM2ADRA2AADORA3
Trifluoromethanesulfonic Acid SCHEMBL6852192 0.89 KCNH2 (0.42) KCNH2ACHECHRM2ADRA2AADORA3
SCHEMBL28947528 0.87 ACHE (0.59) KCNH2ACHECHRM2ADRA2AADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 261 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260133459-A1 LOW-TEMPERATURE SOLID POLYMER ELECTROLYTE FOR ELECTROCHROMIC DEVICES LANNRAY ADVANCED MAT CO LTD (CN) 2026-05-14 US claimed
EP-3244987-B1 SEPARATIONS WITH IONIC LIQUID SOLVENTS CHEVRON PHILLIPS CHEMICAL CO LP (US) 2022-06-22 EP claimed
CN-114575040-A Cellulose spray cloth and preparation method and application thereof 北京林业大学 2022-06-03 CN claimed
US-20210395906-A1 ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY CUSTOMARRAY INC (US) 2021-12-23 US claimed
CN-112086564-A Passivating agent and passivation method thereof and method for preparing semiconductor film 杭州纤纳光电科技有限公司 2020-12-15 CN claimed
CN-111435705-A Repairing agent and repairing method thereof and method for preparing photoelectric film 杭州纤纳光电科技有限公司 2020-07-21 CN claimed
EP-3244987-A1 SEPARATIONS WITH IONIC LIQUID SOLVENTS Chevron Phillips Chemical Company LP (US) 2017-11-22 EP claimed
US-20150133711-A1 Separations With Ionic Liquid Solvents CHEVRON PHILLIPS CHEMICAL COMPANY LP 2015-05-14 US claimed
US-8809844-B2 Foldable thin film transistor SAMSUNG ELECTRONICS CO., LTD. (KR) 2014-08-19 US claimed
EP-1658268-B1 MIXTURES OF IONIC LIQUIDS WITH LEWIS ACIDS NOVARTIS AG (CH) 2014-02-12 EP claimed
US-20070176148-A1 Organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2007-08-02 US claimed
CN-101007940-A High efficiency organic electroluminescence device SAMSUNG SDI CO LTD (KR) 2007-08-01 CN claimed
EP-1805206-A2 ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE Combimatrix Corporation (US) 2007-07-11 EP claimed
US-20070034513-A1 Electrochemical deblocking solution for electrochemical oligomer synthesis on an electrode array COMBIMATRIX CORPORATION 2007-02-15 US claimed
WO-2007012825-A1 DEHYDRATION PROCESS BP P.L.C. (GB) 2007-02-01 WO claimed
WO-2007006418-A1 IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-01-18 WO claimed
WO-2006131234-A1 COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-12-14 WO claimed
WO-2006105037-A2 ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY COMBIMATRIX CORPORATION (US) 2006-10-05 WO claimed
WO-2006031814-A2 ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE COMBIMATRIX CORPORATION (US) 2006-03-23 WO claimed
US-20060054511-A1 Electrochemical deblocking using a hydrazine derivative CUSTOMARRAY, INC. 2006-03-16 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210395906-A1 ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY DNMT1, DNASE1, DNPEP KCNH2 484/4885ACHE 701/4885CHRM2 3540/4885
US-20260133459-A1 LOW-TEMPERATURE SOLID POLYMER ELECTROLYTE FOR ELECTROCHROMIC DEVICES EEF2, PHF2, EIF4E KCNH2 22/4885ACHE 2449/4885CHRM2 2873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.